ArticleThoracic cancer2022

Serum IL-35 levels is a new candidate biomarker of cancer-related cachexia in stage IV non-small cell lung cancer.

Zengxun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.